GGrantIndex
Sort

17,828 grants matching crispr

RNA interference-based screens for molecular targets in cancer

$1,418,261
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Oncogenic mechanisms and molecular targets in lymphoma

$1,418,261
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Developmental Mechanisms of Human Meningomyelocele

$1,417,141
Joseph G Gleeson · University Of California, San Diego · P01 · FY2021 · HD

Regulated expression and developmental functions of the H19 long noncoding RNA

$1,416,786
Karl Eric Pfeifer · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD

DEVELOPMENT OF PLX-R18 CELL THERAPY AS A COUNTERMEASURE FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME

$1,416,470
Chen Franco-Yehuda · Pluristem, Ltd · N01 · FY2024 · AI

Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis

$1,416,075
Paul Stephen Keim · Northern Arizona University · U19 · FY2024 · AI

Pre-clinical and clinical studies of NTBC and other compounds as potential treatments for albinism

$1,414,848
Brian Brooks · National Eye Institute · ZIA · FY2021 · EY

Regulated expression and developmental functions of the H19 long noncoding RNA

$1,414,266
Karl Eric Pfeifer · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD

Synthetic Cell State Engineering for Primary Human Cellular Therapies

$1,413,277
Theodore Lee Roth · Stanford University · DP2 · FY2025 · CA

Functionally Assessing Transcriptional Enhancers In Vivo

$1,412,170
Len Alexander Pennacchio · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2024 · HG

Functionally Assessing Transcriptional Enhancers In Vivo

$1,412,170
Len Alexander Pennacchio · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2025 · HG

RP2: Targeting genes and pathways for autophagy-dependent inhibition of bacterial infection

$1,411,732
Ramnik J Xavier · Ut Southwestern Medical Center · U19 · FY2023 · AI

Mechanism of repeat expansion and chromosome fragility in Fragile X syndrome

$1,411,136
Karen P. Usdin · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Neuronal Circuits Controlling Behavior: Genetic Analysis in Zebrafish

$1,410,978
Harold Burgess · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD

Identifying novel modes of oncogenic signaling in multiple myeloma

$1,410,512
Ryan Young · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Alveolus as Incubator: Functional Genomic Dissection of the Host Response to SARS-CoV-2 Infection.

$1,410,500
Anthony W Orvedahl · Washington University · DP2 · FY2021 · GM

Genetic models of sporadic Alzheimers Disease in the marmoset

$1,410,426
Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2021 · AG

Genetic models of sporadic Alzheimers Disease in the marmoset

$1,410,426
Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2022 · AG

Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease

$1,410,149
Jeffery M. Vance · University Of Miami School Of Medicine · U01 · FY2021 · AG

Neuronal Circuits Controlling Behavior: Genetic Analysis in Zebrafish

$1,407,351
Harold Burgess · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD

Research Capacity Core

$1,406,492
Josiah Ochieng · Meharry Medical College · U54 · FY2024 · MD

Functional Genomics of Bipolar Disorder

$1,405,320
Francis J McMahon · National Institute Of Mental Health · ZIA · FY2015 · MH

Higher Order Chromatin and Genetic Risk for Alzheimer's Disease

$1,403,120
Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG

Biological functions and post-transcriptional regulation of microRNAs

$1,400,539
Katherine McJunkin · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

NEI Genetic Engineering Core

$1,400,394
Lijin Dong · National Eye Institute · ZIC · FY2018 · EY